Progress in gene therapy treatments for prostate cancer-Reference-Cited by-同舟云学术

Progress in gene therapy treatments for prostate cancer

Published:2021-05-25 Issue: Volume: Page:
ISSN:0885-4513
Container-title:Biotechnology and Applied Biochemistry
language:en
Short-container-title:Biotechnology and Applied Biochemistry

Author:

Xue Jingxin¹^ORCID,Chen Keming¹,Hu Heyi¹,Gopinath Subash C.B.²³^ORCID

Affiliation:

1. Department of Urology Affiliated Jinan Third Hospital of Jining Medical University, Jining Medical University Jinan Shandong China

2. Institute of Nano Electronic Engineering Universiti Malaysia Perlis (UniMAP) Kangar Perlis 01000 Malaysia

3. Faculty of Chemical Engineering Technology Universiti Malaysia Perlis (UniMAP) Arau Perlis 02600 Malaysia

Publisher

Wiley

Subject

Process Chemistry and Technology,Drug Discovery,Applied Microbiology and Biotechnology,Biomedical Engineering,Molecular Medicine,General Medicine,Bioengineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bab.2193

Reference68 articles.

1. Functional roles of antisense enhancer RNA for promoting prostate cancer progression;Pan CW;Theranostics,2021

2. Targeted nonviral gene therapy in prostate cancer

3. Prostate carcinogenesis: inflammatory storms

4. Interleukin-armed chimeric antigen receptor-modified T cells for cancer immunotherapy

5. The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of action of Sappan lignum for prostate cancer treatment: network pharmacology, molecular docking and experimental validation;Frontiers in Pharmacology;2024-09-10

2. Advancements of gene therapy in cancer treatment: A comprehensive review;Pathology - Research and Practice;2024-09

3. Emerging trends in nano-carrier based gene delivery systems for targeted cancer therapy;Journal of Drug Delivery Science and Technology;2024-05

4. Synthesis and evaluation of gene delivery vectors based on PEI-modified metal-organic framework (MOF) nanoparticles;IRAN J BASIC MED SCI;2024

5. Serine/threonine kinase 36 induced epithelial-mesenchymal transition promotes docetaxel resistance in prostate cancer;Scientific Reports;2024-01-06